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Introduction
Benign multicystic mesothelioma (BMCM)
is a rare tumor of the abdomen-peritoneum of
unknown etiology.
1 This benign tumor was ini-
tially  described  by  Plaut  in  1928  when  he
observed loose cysts in the pelvis during a sur-
gery for a uterine leiomyoma.
2 The mesothelial
origin was later confirmed by electron micro-
scopy by Mennemeyer and Smith in 1979.
3 To
date,  there  are  approximately  140  cases  of
BMCM reported in the literature.
4 This disease
primarily  occurs  in  pre-menopausal  women
and  is  associated  with  a  history  of  pelvic
inflammatory  disease,  prior  abdominal  sur-
gery, and endometriosis.
4,5 The pathogenesis of
this disease remains controversial, with possi-
ble etiologies including a neoplastic versus a
reactive process.
5
In the literature, a few case reports discuss
a possible genetic or familial association with
BMCM.
6 Specifically,  one  report  describes  a
man  with  familial  Mediterranean  fever  who
developed BMCM. Although familial Mediter-
ranean  fever  is  associated  with  malignant
mesothelioma, he had only BMCM, and did not
suffer from malignant mesothelioma.
6 A genet-
ic evaluation and chromosomal analysis were
not able to identify a specific genetic cause of
the family’s pattern of disease.
This case report describes two female sib-
lings  diagnosed  with  BMCM.  In  addition,  a
third sister also had findings consistent with
BMCM, however, the discrete histological diag-
nosis was never confirmed.
Case #1
K.S. is a 53-year-old G3P3003 menstruating
female who presented to her gynecologist with
a complaint of intermittent urinary urgency.
She denied symptoms of bloating, fullness, and
constipation.  Her  gynecological  history  was
significant for menarche at age 13 with regu-
lar menses, use of oral contraceptive pills for 5
years, and normal pap smears in her lifetime.
The  patient  had  three  normal  spontaneous
vaginal deliveries. Her medical history was sig-
nificant  for  hypothyroidism,  which  was  well
controlled on levo-thyroxine. Her past surger-
ies included a benign breast biopsy, wisdom
teeth  extraction,  and  removal  of  her  tonsils
and adenoids. Her family history was signifi-
cant for a maternal grandfather who died of
breast  cancer  in  his  80’s  and  an  aunt  with
colon cancer. 
On physical exam the patient was a thin,
healthy-appearing woman. She was normoten-
sive, with a blood pressure of 144/78 mmHg,
and  a  body  mass  index  of  22.8  kg/m
2.  Her
abdomen was soft with no masses appreciated.
Her pelvic exam was notable for a 7 cm irregu-
lar mass in the cul-de-sac, which was non-ten-
der and immobile. 
A  transvaginal  ultrasound  was  performed
that revealed bilateral ovarian masses. For fur-
ther evaluation, an MRI was obtained, which
revealed a multilobulated cystic structure with
septations  present  in  the  cul-de-sac.  CA-125
level was normal (12 U/mL).
The patient underwent a total abdominal hys-
terectomy, bilateral salpingo-oophorectomy, and
tumor debulking to no visible residual disease.
Intra-operative  findings  included  a  14–week
sized uterus with a globular contour and numer-
ous  cystic,  mucoid  lesions  on  the  uterine
serosa. The right ovary had mucinous, grape-
like cystic structures attached. The pelvic peri-
toneum had mucin-like cystic masses scattered
along the pelvic sidewalls as well as in the cul-
de-sac. Numerous similar cystic lesions were
present  on  the  omentum  at  the  level  of  the
hepatic flexure, along the right lateral margin of
the infracolic omentum and on the mesentery of
the terminal ileum. The fallopian tubes and the
left ovary appeared to be within normal limits.
Intra-operative examination revealed bilat-
eral ovaries and fallopian tubes to have multi-
ple cystic structures on their serosal surfaces.
The cysts ranged in size from 2 mm to 4.5 cm,
and  were  clear-walled  structures  containing
thin, clear fluid. The cyst walls contained no
papillary projections and were smooth. Many of
the  pelvic  sidewall  cystic  masses  that  were
resected  were  macroscopically  tan-red  in
appearance with irregular membranous tissue.
The largest of these cystic masses measured
9.0x5.0x0.2  cm.  On  microscopic  evaluation,
these cysts were lined with benign appearing
mesothelial  cells  that  were  flat  to  cuboidal.
They stained positive for calretinin immunos-
tain further supporting the diagnosis of benign
multicystic mesothelioma. 
The final diagnosis was benign multicystic
mesothelioma, endometriosis, and focal endo-
salpingiosis.  The  patient  had  an  uneventful
recovery and has had no recurrences one year
after surgery.
Case #2
M.S.,  the  younger  sister  of  K.S.,  was  35-
years old when a pelvic mass was discovered
on routine gynecologic exam. She is a G3P3003
with  normal  spontaneous  vaginal  deliveries
and a surgical history significant only for wis-
dom teeth removal. She is a non-smoker, takes
no  medications,  and  is  allergic  to  trimetho-
prim-sulfamethoxazole. 
After the incidental finding of a pelvic mass,
she underwent a CT scan of the abdomen and
pelvis that confirmed a pelvic mass measuring
8.6x5.3x4.9 cm. It was located posterior to the
uterus,  extending  to  the  cul-de-sac,  and
described as multicystic-appearing in nature;
no free fluid or ascites were noted. The patient
complained of occasional left lower quadrant
discomfort. Serum tumor markers were within
normal limits.
She  underwent  a  supracervical  abdominal
hysterectomy with bilateral salpingo-oophorec-
tomy and lysis of adhesions. Intraoperatively,
multiple cystic grape-like structures along the
pelvic  sidewall,  cul-de-sac  peritoneum,  and
bladder were described. Intra-operative frozen
section  returned  with  findings  of  a  benign
multicystic mesothelioma. 
The masses were tan-pink in color, polycys-
tic,  and  semi-translucent  on  macroscopic
inspection. There were multiple varied sizes of
translucent  “grape-like”  cysts  present  along
the  ovaries  and  fallopian  tubes  bilaterally.
Microscopic  evaluation  revealed  the  cystic
structures to be of varying size, and lined with
flat or low cuboidal mesothelial cells contain-
ing serous fluid. Multicystic nodules contained
marked congested fibrovascular tissue, some
with inflammatory cells with varying degrees
of severity. Several of the nodules contained
adenomatoid tumors. 
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After her surgery, the patient was started on
continuous estrogen replacement therapy due
to her desire to prevent estrogen withdrawal
symptoms. She was then followed closely with
ultrasounds and CT scans of the abdomen and
pelvis. Two years after her surgery, the BMCM
recurred  with  multiple  cysts  throughout  her
pelvis, which has been managed conservative-
ly without further surgery. The patient remains
asymptomatic, and her lesions remain stable.
Case #3
The two sisters presented above have a third
sister, who, at age 46, presented to her gyne-
cologist with a persistent left ovarian cyst. She
underwent a laparoscopic bilateral salpingec-
tomy. Intraoperatively, multiple small “blister-
like” excrescences in the cul-de-sac and on the
surface of the right ovary were noted. The peri-
toneal surfaces and omentum were found to
have  multiple  “blister-like”  excrescences.  In
addition,  the  distal  right  fallopian  tube  con-
tained a “simple” cystic structure and the dis-
tal left fallopian tube had a multiloculated cys-
tic  structure.  Intra-operative  frozen  section
described  these  specimens  to  be  benign  in
nature.  The  final  pathology  returned  with
benign mesothelial and serous cysts, hydros-
alpinges, and Walthard cysts. No further stain-
ing was performed to suggest or exclude the
diagnosis  of  BMCM.  This  sister  remains
asymptomatic and has had no further surger-
ies.
Discussion
Benign multicystic mesothelioma is a rare
lesion  that  most  commonly  arises  from  the
surfaces of the pelvic peritoneum. It has had
several different names used in the literature
due to an ongoing debate regarding its origin.
Alternate  nomenclature  for  this  disease
includes: peritoneal inclusion cyst, multilocu-
lar  inclusion  cyst,  and  multicystic  mesothe-
lioma.
7 It  most  commonly  occurs  in  pre-
menopausal women with a mean age of onset
of  37  years.
8 It  has  been  described  in  post-
menopausal women, and 16-17% of cases have
been reported in men with a mean age of onset
of  47  years.
7,9 There  is  no  association  with
asbestos exposure.
8,10
Most  patients  are  diagnosed  incidentally
either  on  physical  exam  or  as  a  finding  on
imaging, or during laparotomy for other indi-
cations.
11 A small number of patients present
with abdominal pain, distention, ascites, dys-
functional uterine bleeding, referred shoulder
pain, dysuria, or dyspareunia.
9,11 Rarely, BMCM
presents as an acute abdomen.
8 Diagnosis is
difficult as there are no reliable clinical find-
ings, features on imaging, or tumor markers
that  are  pathogonomic  for  this  tumor.
12
Ultrasound and CT scan reveal cystic masses
that cannot be differentiated from other pelvic
pathology.
Differential diagnosis includes both benign
and  malignant  abdominal  lesions  including
cystic  lymphangioma,  endosalpingiosis,  ade-
nomatoid tumors, mesonephric duct remnants,
malignant mesothelioma, sarcoma, and non-
Hodgkin’s  lymphoma.
8,11 Clinically,  the  differ-
ential diagnosis of BMCM from other ovarian
tumors is important, since BMCM can be treat-
ed with ovarian preservation techniques.
11
The pathogenesis of BMCM remains contro-
versial. Some believe it is a reactive process
while others believe it is a neoplastic process.
There is an association between prior surger-
ies,  endometriosis,  pelvic  inflammatory  dis-
ease,  intra-peritoneal  inflammation  and
BMCM,  which  suggests  a  possible  reactive
process.  The  hypothesis  behind  the  reactive
process pathogenesis says that chronic peri-
toneal  irritation  may  react  with  mesothelial
cell entrapment, and cause reactive prolifera-
tion and cyst formation.
5,11 On the other hand,
others believe that a neoplastic process is the
cause,  with  a  slow  progressive  nature  and
marked tendency to recur after multiple surgi-
cal resections.
5
The tumor is usually found on the surfaces
of the pelvic viscera, especially on the peri-
toneum of the cul-de-sac, rectum, and bladder.
8
Macroscopically, BMCM appears as solitary or
multi-septated,  translucent,  grape-like  cysts
with thin walls that are separated by fibrous
tissue.
6,8 Cyst  size  can  vary  from  1-2  mm  to
greater than 30 cm, and are usually multilocu-
lar.
6,8 The cysts are either empty or filled with
serous, bloody or mucinous fluid. At the time of
diagnosis, the mean cyst diameter is 13 cm.
7 In
women it usually arises along the peritoneal
surfaces of the uterus and rectum. In men it
arises  along  the  peritoneal  surfaces  of  the
bladder and rectum.
7
Microscopic examination reveals cysts lined
by  a  single  layer  of  flattened  or  cuboidal
mesothelial cells without atypia or mitosis.
6,8,10
Focal  reactive  mesothelial  changes  such  as
hobnail-shaped  cells  and  foci  of  mesothelial
hyperplasia can be present.
7 With immunohis-
tochemical analysis, these cells stain positive
for calretinin and cytokeratins, a reflection of
their mesothelial origin.
7
Treatment of BMCM primarily involves sur-
gery, as complete resection has been shown to
be the only effective treatment.
6 Some authors
have used more aggressive methods with some
success  such  as  laparoscopic  laser  ablation
with potassium titanyl phosphate,
13 sclerosing
therapy with tetracycline, hyperthermic peri-
toneal infusion with cisplatin, and peritonecto-
my  with  intraperitoneal  chemotherapy.
14,15 As
recurrence  is  common,  several  investigators
have proposed alternative and more conserva-
tive treatments with hormonal therapy. 
Hormonal  regulation  of  BMCM  has  been
suggested by several authors who point to the
characteristically  pre-menopausal  state  of
patients with this disease.
16-18 Additionally, this
disease  rarely  occurs  in  post-menopausal
women or after bilateral salpingoophorectomy.
At  present,  scant  literature  exists  regarding
estrogen receptor (ER) or progesterone recep-
tor (PR) expression in BMCM. A case series by
Sawh et al.
16 found that some BMCM tumors
stain  positive  for  either  estrogen  or  proges-
terone receptors, or both. They identified 17
cases of BMCM at their institution spanning
over a 20 year period with sufficient clinical
and  pathological  tissue  for  evaluation.
Immunohistochemical staining for ER and PR
were  performed  on  all  samples  and  among
these three were identified with ER and or PR
expression. One case revealed the mesothelial
lining to be diffusely positive for ER only. A sec-
ond case was focally positive for PR and a third
case revealed the mesothelial lining to be focal-
ly positive for both ER and PR. These authors
speculate that the finding of hormone receptor
expression in only 3 of their 17 patients may be
the result of metaplastic changes in the cells
lining the cyst walls. Alternatively, immunohis-
tochemical  studies  may  not  be  sensitive
enough  to  detect  clinically  relevant  levels  of
hormone receptor expression.
Experimental treatment with anti-estrogen
therapy (e.g., tamoxifen), GnRH agonists (e.g.,
leuprolide  acetate),  and  intraperitoneal
chemotherapy have been attempted with vary-
ing  degrees  of  success.
11 Letterie  et  al.
17,18
reported  on  two  women  with  BMCM  who
declined surgical management in favor of med-
ical  management.  The  first  case  report
describes a 17-year old woman who recurred
twice after surgical intervention and was treat-
ed medically. She was started on a GnRH ago-
nist  (leuprolide),  which  initially  caused  an
increase  in  the  size  of  her  pelvic  mass  as
measured on ultrasound. After one month of
treatment a decrease in the pelvic mass size
was observed. After 6 months of treatment she
began  supplemental  estrogen  and  proges-
terone  to  counteract  the  side  effects  of  the
GnRH agonist. Within 4 weeks an increase in
mass  size  was  appreciated  and  the  patient
once again became symptomatic. No immuno-
histochemical staining for estrogen or proges-
terone receptors were performed on the surgi-
cal specimens from her initial surgeries.
A second case described by Letterie et al.
18
describes a pre-menopausal woman who was
treated with tamoxifen. Within 4 weeks she
reported a significant reduction in pelvic pain.
Imaging with ultrasound confirmed a decrease
in pelvic mass size. However, no tissue was
obtained for histopathologic evaluation.
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True prognosis of BMCM is unclear. The dis-
ease has a high recurrence rate of up to 50%.
19
Time to recurrence varies from a few months
to years, with an average of 32 months.
10 In
addition, size of lesions, site of disease, extent
of  disease  burden  and  previous  recurrence
have not been found to be helpful in predicting
future recurrences.
16 It is recommended that
patients be followed throughout their lifetime
for recurrences. 
Additionally, due to high recurrence rates,
some authors regard BMCM as a borderline
tumor, possibly between the realm of an adeno-
matoid tumor and malignant mesothelioma.
6
There are only two case reports to date in the
current literature that describe the malignant
transformation of BMCM to malignant meso-
thelioma.
5 One  of  these  cases  presented  as
both benign and malignant disease simultane-
ously, which makes it impossible to ascertain
which came first. The second case, however,
reports of a young woman who was being fol-
lowed for benign disease, and after 10 years of
conservative management with biopsy-proven
benign  disease,  malignant  transformation
occurred.
5
A familial or genetic association with BMCM
has been rarely reported in the literature.
6 As
stated in the introduction, there are a few case
reports  describing  the  already  well-known
association between malignant mesothelioma
and  familial  Mediterranean  fever.  However,
there is another case report of a patient with
familial Mediterranean fever who subsequent-
ly developed BMCM.
1 A different case report
discusses  two  sisters  both  with  a  history  of
diverticulosis  and  cataracts  who  later  devel-
oped BMCM. In addition to diverticulosis and
early onset cataracts with retinal detachments,
their  family  history  was  also  significant  for
ovarian cancer, colon cancer, and congenital
defects including renal agenesis, diaphragmat-
ic hernia, and anencephaly.
In our case report of three sisters, there are
no obvious or grossly unusual familial diseases
or  anomalies  in  their  family  history.
Additionally, none of the sisters reported histo-
ries of the risk factors often associated with
BMCM such as prior surgery, pelvic inflamma-
tory disease or endometriosis. 
In conclusion, BMCM is a rare disease with
an uncertain prognosis. It has a high recur-
rence rate with a high likelihood for multiple
medical  and  surgical  treatments  over  a  life-
time. The purported benign nature of this dis-
ease  also  remains  in  question.  Therefore,  a
high level of suspicion with a lifetime of close
follow-up are required for these patients. At
present, our case report is one of few illustrat-
ing a possible genetic association with BMCM.
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